首页> 外国专利> Therapeutical composition based on amlodipine-besylate and exhibiting increased stability

Therapeutical composition based on amlodipine-besylate and exhibiting increased stability

机译:基于氨氯地平苯磺酸盐并显示出增加的稳定性的治疗组合物

摘要

the medicinal product on the basis of amlodipine is zvu00fdsenou stability, comprising 3472% by weight. amlodipine - besilu00e1tu, 65 to 91% by weight. microcrystalline cellulose; 2 to 15% by weight.hydrogenfosforecnanu phosphate; 2.0 to 6.0% by weight. sodium salts karboxymethylskrobu and 0.25 to 5.0% by weight. stearanu sodium and possibly contains 0.0001 to 0.5% by weight.stearanu horecnatu00e9ho, vztazeno to weight the tablets or capsules.
机译:基于氨氯地平的药用产品为zv稳定性,占3472重量%。氨氯地平-besil u00e1tu,按重量计占65%至91%。微晶纤维素; 2至15重量%。 2.0至6.0重量%。钠盐和0.25-5.0%(重量)。硬脂酸钠,可能含有0.0001至0.5%的重量。以片剂或胶囊的重量为准。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号